Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)

Japan flag Japan · Delayed Price · Currency is JPY
6,030.00
0.00 (0.00%)
At close: Feb 27, 2026
38.94%
Market Cap 422.54B
Revenue (ttm) 159.27B
Net Income (ttm) 19.99B
Shares Out 70.07M
EPS (ttm) 277.12
PE Ratio 21.76
Forward PE 24.70
Dividend 45.00 (0.75%)
Ex-Dividend Date n/a
Volume 1,699,900
Average Volume 808,775
Open 6,031.00
Previous Close 6,030.00
Day's Range 6,028.00 - 6,037.00
52-Week Range 3,783.00 - 6,695.00
Beta 0.35
RSI 45.51
Earnings Date Apr 9, 2026

About TYO:4530

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company offers OTC products, such as external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. It also exports its products to Asi... [Read more]

Sector Healthcare
Founded 1847
Employees 2,799
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4530
Full Company Profile

Financial Performance

In fiscal year 2025, TYO:4530's revenue was 156.01 billion, an increase of 10.09% compared to the previous year's 141.71 billion. Earnings were 21.76 billion, an increase of 55.76%.

Financial Statements

News

There is no news available yet.